A Case of Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma.
- Author:
Woon Kyong CHUNG
1
;
Myoung Shin KIM
;
Seong Min KANG
;
Sung Eun CHANG
;
Mi Woo LEE
;
Jee Ho CHOI
;
Kee Chan MOON
Author Information
1. Department of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
CD4;
CHOP chemotherapy;
Lymphoma;
Pleomorphic;
Small/medium-sized
- MeSH:
Adult;
Cyclophosphamide;
Doxorubicin;
Drug Therapy, Combination;
Female;
Humans;
Lymphoma;
Lymphoma, T-Cell;
Lymphoma, T-Cell, Cutaneous;
Prednisolone;
Rare Diseases;
T-Lymphocytes;
Vincristine
- From:Korean Journal of Dermatology
2009;47(3):338-342
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma (CSMTCL) is a rare disease constituting 2% of all cutaneous T-cell lymphomas. In most cases, CSMTCL occurs as a solitary lesion and has an indolent course. Here we present a 42-year-old woman with multiple, localized, recurrent, erythematous papules and macules that developed after combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP).
